magnesium-diasporal
lex ano, uab - magnis - granulės geriamajam tirpalui - 300 mg/5 g - magnesium citrate
magnesium-diasporal
protina pharmazeutische gesellschaft mbh - magnis - granulės geriamajam tirpalui - 295,7 mg/5 g - magnesium citrate
magnesium-diasporal orange
protina pharmazeutische gesellschaft mbh - magnis - kietosios pastilės - 98,6 mg - magnesium citrate
paxeladine
ipsen consumer healthcare - okseladino-vandenilio citratas - sirupas - 2 mg/ml - oxeladin
regiocit
baxter holding b.v. - natrio chloridas/natrio citratas - hemofiltracijos tirpalas - 5,03 g/5,29 g/l - hemofiltrates
remolexam
vital pharma gmbh - meloksikamas - injekcinis tirpalas - 7,5 mg; 15 mg/1,5 ml - meloxicam
ulcamed
krka, d.d., novo mesto - bismuto oksidas - plėvele dengtos tabletės - 120 mg - bismuth subcitrate
medoclav
medochemie ltd. - amoksicilinas/klavulano rūgštis - milteliai geriamajai suspensijai - 400 mg/57 mg/5 ml - amoxicillin and beta-lactamase inhibitor
ulcamed
ideal trade links, uab - bismuto oksidas - plėvele dengtos tabletės - 120 mg - bismuth subcitrate
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antinavikiniai vaistai - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.